Remix Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Remix Therapeutics's estimated annual revenue is currently $13.2M per year.
- Remix Therapeutics's estimated revenue per employee is $155,000
- Remix Therapeutics's total funding is $213M.
Employee Data
- Remix Therapeutics has 85 Employees.
- Remix Therapeutics grew their employee count by 5% last year.
Remix Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | SVP, Head Drug Discovery at Remix Therapeutics | Reveal Email/Phone |
5 | VP, Human Resources | Reveal Email/Phone |
6 | VP, Biological Exploration and Translational Research | Reveal Email/Phone |
7 | VP, Program Management | Reveal Email/Phone |
8 | Head Medicinal Chemistry | Reveal Email/Phone |
9 | VP, Development Operations & Patient Advocacy | Reveal Email/Phone |
10 | SVP, Biomolecular Sciences and Lead Discovery | Reveal Email/Phone |
Remix Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Remix Therapeutics?
Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
keywords:N/A
$213M
Total Funding
85
Number of Employees
$13.2M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Remix Therapeutics News
... Johnson & Johnson's unit, partnered with Remix Therapeutics, a biotech company developing small molecule therapies designed to reprogram...
emix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in...
Biotechnology startup Remix Therapeutics Inc. has secured $81 million from venture capitalists to develop medications that could treat a variety of diseases by influencing how cells process RNA. Most drugs interact with disease proteins. Remix and some other startups instead seek to influence R ...
Drugs normally target problematic proteins, but Peter Smith, Ph.D., believes his team at Remix Therapeutics can disrupt the process of a protein’s creation before it starts causing disease. Investors believe in him, too—the company launches with $81 million in funding to develop small molecules ...
Biotechnology startup Remix Therapeutics Inc. has secured $81 million from venture capitalists to develop medications that could treat a variety of diseases by influencing how cells process RNA. Most drugs interact with disease proteins. Remix and some other startups instead seek to influence R ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23M | 85 | -19% | N/A |
#2 | $7.5M | 85 | 23% | N/A |
#3 | $12.3M | 85 | N/A | N/A |
#4 | $13.2M | 85 | -2% | N/A |
#5 | $23M | 85 | 1% | N/A |